Associated Papers
Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma.
Li Q et al.
Biomarker Research, 2020
Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
Lennerz JK et al.
Oncotarget, 2015
26336985 (PubMed )
Supplement: oncotarget-06-29097-s002.xls › Minor
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.
Schif B et al.
Oncotarget, 2013
23296022 (PubMed )
Supplement: oncotarget-04-035-s001.pdf
Select a paper to view details